Institutional Ownership Acrivon Therapeutics, Inc. (ACRV)
This table provides information about the institutional ownership of Acrivon Therapeutics, Inc. (ACRV). We have compiled data on the 53 institutions that hold shares in the stock, with a total of 23.7 Million shares, which have been reported (via 13F filing form) to have a value of $0.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2024 Q2 2024 |
8,340,508
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
Perceptive Advisors LLC
New York, NY |
Aug 16, 2024 Q2 2024 |
5,360,858
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 78.23%
|
|
Sands Capital Ventures, LLC
Arlington, VA |
Aug 13, 2024 Q2 2024 |
2,122,605
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 28.44%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
2,119,646
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 26.17%
|
|
Marshall Wace, LLP
London, X0 |
Aug 14, 2024 Q2 2024 |
948,866
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 58.81%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 13, 2024 Q2 2024 |
888,130
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
767,020
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 3.11%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
745,510
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 46.99%
|
|
Paradigm Biocapital Advisors LP
New York, NY |
Aug 14, 2024 Q2 2024 |
659,724
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
308,393
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 26.99%
|
|
Health Cor Management, L.P.
New York, NY |
Feb 14, 2023 Q4 2022 |
284,201
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
178,663
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 34.05%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2024 Q2 2024 |
143,958
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 86.04%
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Aug 14, 2024 Q2 2024 |
121,351
shares
|
$0
0.0% of portfolio
|
Q2 2024
Reduced 7.61%
|
|
Northern Trust Corp
Chicago, IL |
Aug 14, 2024 Q2 2024 |
114,053
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 5.85%
|
|
Ubs Oconnor LLC
Chicago, IL |
Aug 14, 2024 Q2 2024 |
105,249
shares
|
$0
0.0% of portfolio
|
Q2 2024
Reduced 17.09%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2024 Q2 2024 |
58,181
shares
|
$0
0.0% of portfolio
|
Q1 2024
Added 81.92%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 09, 2024 Q2 2024 |
54,500
shares
|
$0
0.0% of portfolio
|
Q2 2024
Reduced 46.88%
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2024 Q2 2024 |
52,885
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|
|
Exchange Traded Concepts, LLC
|
Aug 13, 2024 Q2 2024 |
42,864
shares
|
$0
0.0% of portfolio
|
Q2 2024
Reduced 23.73%
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
30,714
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2024 Q2 2024 |
27,550
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 356.2%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 13, 2024 Q2 2024 |
24,384
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
Barclays PLC
London, X0 |
Aug 14, 2024 Q2 2024 |
22,033
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 3.32%
|
|
Morgan Stanley
New York, NY |
Aug 14, 2024 Q2 2024 |
17,249
shares
|
$0
0.0% of portfolio
|
Q1 2024
Reduced 32.73%
|